EPISODE · Feb 21, 2023 · 32 MIN
Chronic Myeloid Leukemia: What HCPs Need to Know
Ehab Atallah, MD, Medical College of Wisconsin, Milwaukee, WI Recorded on January 24, 2023 Ehab Atallah, MD Professor of Medicine Associate Director, Cancer Service Line Section Head, Hematologic Malignancies Division of Hematology and Oncology Medical College of Wisconsin Milwaukee, WI In this episode, Dr. Ken Miller sits down with Dr. Ehab Atallah, from the Medical College of Wisconsin, to discuss chronic myeloid leukemia (CML) including the development of tyrosine kinase inhibitors (TKIs), challenges with adherence to treatment, side effect management, and long-term and late effects, including cardiac toxicities. Dr. Atallah describes the work of the H. Jean Khoury Cure CML Consortium, shares his insights in to transitioning patients off TKIs, experience with his patients living with measurable residual disease, and excitement about the future of CML therapy. Learn more by tuning in today!
NOW PLAYING
Chronic Myeloid Leukemia: What HCPs Need to Know
No transcript for this episode yet
Similar Episodes
May 4, 2026 ·16m
Apr 27, 2026 ·17m
Apr 13, 2026 ·16m
Apr 6, 2026 ·16m
Mar 30, 2026 ·16m
Mar 23, 2026 ·17m